
Where MedTech professionals gain clarity and confidence to navigate complex risk, quality, and leadership challenges.
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 578 | Founded | 4 years ago | Last Issue | 6 days ago |
| Active | |||||

In responding to Comment #34 in the preamble of the QMSR1, FDA addresses an important quesiton - does QMSR need a separate definition of “accessory”?
FDA concluded that it does not. For purposes of QMSR, FDA considers an accessory to be a...
Dear colleagues:
At product launch, manufacturers may have strong visibility into the supplier processes and characteristics that support device safety. Specifications are current, process validations are recent, safety-related characteris...
“ISO 14971 and ICH Q9 are not competing frameworks. They are asking different questions about risk.”
In this episode of the Let’s Talk Risk! conversation, host Naveen Agarwal speaks with Susan Neadle, Principal Consultant and...
In responding to Comment #33 in the preamble of the QMSR1, FDA addresses an important boundary question: when is something a component, and when has it become a finished device?
That distinction matters because QMSR generally applies direc...
Dear colleagues:
In a recent post, we looked at whether characteristics related to safety remain traceable to the hazards and harms they influence, and to the processes and suppliers responsible for controlling them.
The next gap often ap...
Subscribers, engagement, traffic and sponsorship for Let's Talk Risk!.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #184 |
The writers behind this newsletter.
MedTech risk management advisor, educator, and creator of Let’s Talk Risk! Sharing ideas on risk, quality, leadership, and decision-making under uncertainty.
You can find recent issues that have been published by Let's Talk Risk! on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Let's Talk Risk!, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Let's Talk Risk! as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Let's Talk Risk! using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Let's Talk Risk!. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.